rss
Heart 98:1182 doi:10.1136/heartjnl-2012-302273
  • PostScript
  • Correspondence

The Authors' reply

  1. Neil Moat5
  1. 1Health Economics, Oxford Outcomes Ltd, Oxford, UK
  2. 2Reimbursement CardioVascular Europe, Medtronic International Trading Sarl, Tolochenaz, Switzerland
  3. 3Cardiovascular Surgery, Munich Heart Centre, Munich, Germany
  4. 4Centre for Health Economics, University of York, York, USA
  5. 5Department of Cardiac Surgery, Royal Brompton Hospital, London, UK
  1. Correspondence to Ms Maureen Watt, Health Economics, Oxford Outcomes Ltd, Seacourt Tower, West Way, Botley, Oxford OX2 0JJ, UK; mozzawatt{at}gmail.com
  1. Contributors All authors contributed to the design, parameterisation and validation of the economic model. MW and SM constructed the economic model and prepared the manuscript. All authors provided significant comments on the content.

The Authors' reply: Van Baal argues that we have under-estimated the cost associated with transcatheter aortic valve implantation (TAVI) and as a result, we have generated an overly-optimistic picture of its cost effectiveness. …

Register for free content


Free sample
This recent issue is free to all users to allow everyone the opportunity to see the full scope and typical content of Heart.
View free sample issue >>

Free archive
The full back archive is now available for Heart. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006, back to volume 1 issue 1.
Register to access the free archive >>

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.